TG Therapeutics DSO Ratio 2011-2026 | TGTX

Annual DSO Ratio TG Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
129	100	-	-	37.9	-	-	228	260	201	446	205	65.1	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
446	37.9	186

Quarterly DSO Ratio TG Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
140	136	121	-	108	92.3	83.4	-	15.6	74.1	50.4	-	42.7	76.1	51.9	-	52	50.3	44.4	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
140	15.6	75.9

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Assembly Biosciences ASMB	25.1	$ 28.49	0.11 %	$ 319 M	USA
Amphastar Pharmaceuticals AMPH	70.9	$ 19.61	0.59 %	$ 917 M	USA
Amarin Corporation plc AMRN	213	$ 14.72	1.59 %	$ 6.11 B	Irlanda
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Ascendis Pharma A/S ASND	132	$ 221.08	-0.36 %	$ 5 B	Danmark
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Axsome Therapeutics AXSM	105	$ 155.38	-0.98 %	$ 7.73 B	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	78.4	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
BioMarin Pharmaceutical BMRN	88.9	$ 55.05	1.7 %	$ 10.6 B	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
AbCellera Biologics ABCL	173	$ 3.46	1.76 %	$ 1.03 B	Canada
Benitec Biopharma BNTC	141	$ 10.92	-0.55 %	$ 449 M	USA
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Calithera Biosciences CALA	28.8	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.1	-	-	$ 3.74 B	USA
Heron Therapeutics HRTX	198	$ 0.79	2.02 %	$ 132 M	USA
Checkpoint Therapeutics CKPT	6.83	-	-	$ 169 M	USA
Clovis Oncology CLVS	65.5	-	-7.23 %	$ 13 M	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Compugen Ltd. CGEN	60.8	$ 2.13	2.15 %	$ 199 M	Israel
Coherus BioSciences CHRS	559	$ 1.58	3.62 %	$ 185 M	USA
Arbutus Biopharma Corporation ABUS	31.5	$ 4.47	5.54 %	$ 742 M	Canada
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Cyclacel Pharmaceuticals CYCC	81.5 K	-	-5.98 %	$ 34.1 M	USA